Skip to main content
. Author manuscript; available in PMC: 2009 Dec 15.
Published in final edited form as: Clin Cancer Res. 2008 Dec 15;14(24):8302–8307. doi: 10.1158/1078-0432.CCR-08-1002

Table 1.

Patient characteristics

Wild-type BRAF group V600E BRAF group
n 6 9
Gender 5 men/1 woman 7 men/2 women
Median age, y (range) 66 (42-78) 55 (44-71)
Stage
III 1 0
IV M1a 2 4
IV M1b 1 1
IV M1c 2 4
Prior therapy*
None 1 0
Chemotherapy 5 9
*

Adjuvant immunotherapy was not considered prior therapy for metastatic melanoma.